Merck (XTER:6MK) FFO


XTER:6MK Merck & Co Inc XTER:6MK
75 GF Score
Price €112.96
GF Value €103.39
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck FFO?

FFO (Funds from operations) only applies to REITs.

XTER:6MK
75GF Score
Merck & Co Inc XTER:6MK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (XTER:6MK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of €112.96 is trading 9.3% above its estimated GF Value™ of €103.39. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for XTER:6MK:

  • FFO:
  • GF Value™: €103.39 vs. price of €112.96 (9.3% above fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the XTER:6MK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
75GF Score

Get the complete analysis for XTER:6MK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€112.96
Price
€103.39
GF Value